SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-111613
Filing Date
2024-04-25
Accepted
2024-04-25 08:07:36
Documents
16
Period of Report
2024-04-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d815676d8k.htm   iXBRL 8-K 27647
2 EX-99.1 d815676dex991.htm EX-99.1 10286
7 GRAPHIC g815676g0425112613166.jpg GRAPHIC 5847
  Complete submission text file 0001193125-24-111613.txt   215383

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA xoma-20240425.xsd EX-101.SCH 3868
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xoma-20240425_def.xml EX-101.DEF 14109
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE xoma-20240425_lab.xml EX-101.LAB 23493
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xoma-20240425_pre.xml EX-101.PRE 15142
20 EXTRACTED XBRL INSTANCE DOCUMENT d815676d8k_htm.xml XML 7095
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 24873098
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)